What is HIV/AIDS?

HIV, or human immunodeficiency virus, attacks CD4 T lymphocytes, or white blood cells that help coordinate the body’s immune response. If HIV is not treated, the number of CD4 cells may gradually decline, increasing susceptibility to opportunistic infections and certain cancers.

AIDS, or acquired immunodeficiency syndrome, is the most advanced stage of HIV infection. A person living with HIV may be diagnosed with AIDS when:

  • The CD4 count falls below 200 cells/mm³; or

  • An AIDS-defining infection, cancer or other condition develops.

AIDS does not mean that the virus has suddenly appeared or spread throughout the body. HIV is already present before this stage develops. Early diagnosis and effective antiretroviral therapy can prevent or greatly delay progression to AIDS.

Types and Stages of HIV Infection

HIV progresses to AIDS when left untreated. The table below shows the progression stages of HIV:

Stage Features
Stage 1: Acute HIV Infection Develops during the first few weeks after infection. The viral load is usually high, and some people develop a flu-like illness, while others have no symptoms.
Stage 2: Chronic HIV Infection HIV remains active but may cause few or no symptoms for several years. Without treatment, CD4 cells gradually decline. Effective ART can suppress the virus and prevent progression.
Stage 3: AIDS Diagnosed when immune suppression becomes severe, the CD4 count falls below 200 cells/mm³ or an AIDS-defining condition develops.

How Common is HIV/AIDS in India?

India has a relatively low national HIV prevalence, but a high absolute number of people living with the infection because of its large population. According to the latest NACO estimates, adult HIV prevalence among people aged 15 - 49 years in India was approximately 0.20% in 2024, with around 25.61 lakh people living with HIV in the country. An estimated 64,470 new HIV infections and 32,160 AIDS-related deaths occurred during the year.

NACO estimates also suggest that since 2010, annual new HIV infections have declined by approximately 49%, while AIDS-related deaths have fallen by approximately 81%. However, HIV prevalence varies considerably between states and districts, making continued testing, early diagnosis and treatment essential.

Symptoms of HIV/AIDS

Symptoms of HIV vary according to the stage of infection and the extent of immune system damage. Common early warning signs and advanced stage symptoms of HIV/AIDS are listed below:

Early Warning Signs Advanced HIV/AIDS Symptoms
  • Fever

  • Chills

  • Sore throat

  • Swollen lymph nodes

  • Skin rash

  • Muscle or joint pain

  • Headache

  • Fatigue

  • Night sweats

  • Mouth ulcers

  • Unexplained weight loss

  • Persistent or recurrent fever

  • Persistent night sweats

  • Chronic diarrhoea

  • Oral thrush or persistent mouth lesions

  • Recurrent or severe infections

  • Persistent cough or breathlessness

  • Unusual skin lesions

  • Memory, concentration or neurological problems

  • Severe weakness or fatigue

Diseases Similar to HIV

HIV may resemble other infections that can be transmitted through sexual contact or infected blood. However, these conditions differ substantially in their causative organisms, affected body systems, complications and treatment outcomes.

A comparative overview of three such conditions is given below for your understanding:

HIV vs Hepatitis B vs Syphilis

Feature HIV Hepatitis B Syphilis
How It Happens Caused by HIV and transmitted through infected blood, semen, vaginal fluids or breast milk. Caused by hepatitis B virus and transmitted through infected blood and certain bodily fluids. Caused by Treponema pallidum and mainly transmitted through sexual contact or from mother to baby.
Location Primarily affects the immune system and CD4 cells. Primarily affects the liver. Can initially affect the skin and mucous membranes and later involve multiple organs.
Associated Symptoms Fever, swollen lymph nodes, rash, recurrent infections and weight loss may occur. Fatigue, nausea, abdominal discomfort, jaundice or no symptoms may occur. Painless sores, rash, swollen lymph nodes and later neurological or cardiovascular complications may occur.
Severity Untreated infection can progress to AIDS and serious complications. Acute infection may resolve, while chronic infection can cause cirrhosis or liver cancer. Untreated infection can progress and damage the brain, nerves, heart or other organs.
Can It Be Reversed? There is currently no cure, but treatment can suppress HIV and prevent progression. Some infections clear naturally, while chronic hepatitis B can usually be controlled but not reliably cured with current treatment. Yes. Appropriate antibiotic treatment can cure the infection, although established organ damage may remain.

Causes of HIV Infection

HIV can be transmitted when infected blood, semen, pre-seminal fluid, vaginal fluid, rectal fluid or breast milk enters another person’s bloodstream or comes into contact with damaged tissue or a mucous membrane.

Common routes of HIV transmission are given below:

  • Sexual Contact: HIV may spread through anal or vaginal sex when effective preventive measures are not used.

  • Shared Needles or Syringes: HIV can also be transmitted by using injection equipment contaminated with infected blood.

  • Pregnancy and Childbirth: A mother living with HIV may transmit the virus to her baby during pregnancy or delivery.

  • Breastfeeding: HIV can pass through breast milk. Antiretroviral treatment, infant preventive medicines and appropriate feeding guidance substantially reduce this risk.

  • Unsafe Blood or Organ Exposure: Transmission may occur through infected blood products or transplanted organs, although screened blood makes this uncommon.

  • Occupational Exposure: Can be acquired by healthcare workers, in some cases, through a needlestick injury or contact with infected blood and through broken skin or mucous membranes.

Factors such as another sexually transmitted infection, a high HIV viral load and sharing injection equipment may increase transmission risk. However, a person taking HIV treatment who maintains an undetectable viral load does not transmit HIV through sex.

HIV does not spread through hugging, touching, sharing food or utensils, toilets, coughing, sneezing, sweat, tears or mosquito bites.

What are the Complications of Untreated HIV?

Untreated HIV can lead to the following complications:

  • Opportunistic Infections: Tuberculosis, severe fungal infections, Pneumocystis pneumonia and other infections may develop when immunity becomes weak.

  • HIV-Associated Cancers: The risk of Kaposi sarcoma, certain lymphomas and cervical cancer may increase.

  • Neurological Problems: Advanced HIV or related infections may affect memory, thinking, coordination or movement.

  • Wasting Syndrome: Severe weight loss, weakness and chronic diarrhoea may occur.

  • Organ Disease: HIV, coinfections or treatment-related factors may affect the kidneys, liver, bones, heart or nervous system.

  • Progression to AIDS: Untreated HIV may eventually cause severe immune suppression.

Modern ART greatly reduces the risk of these complications. Tuberculosis remains an especially important opportunistic infection among people living with HIV in India.

When Should You See a Healthcare Provider?

It is recommended to seek medical advice or HIV testing when:

  • A possible sexual or blood exposure has occurred.

  • A condom broke during a potentially risky exposure.

  • Needles or injection equipment were shared.

  • A sexual partner has received an HIV diagnosis.

  • A needlestick or occupational blood exposure occurred.

  • Pregnancy is planned or confirmed.

  • Recurrent infections, unexplained weight loss or persistent fever develop.

  • Routine screening is due.

How is HIV Diagnosed?

HIV cannot be diagnosed through symptoms, medical history or physical examination alone. Laboratory testing is required. In India, a reactive screening result must be confirmed through the testing algorithm recommended by NACO.

An overview of the diagnostic process used for HIV testing is given below:

Test Purpose
Rapid HIV Antibody Test Screens for HIV antibodies and may provide results within approximately 20-30 minutes
Antigen/Antibody Test Detects HIV antibodies and the p24 antigen, allowing earlier detection than an antibody-only test
NACO Confirmatory Testing Algorithm Uses additional tests with different principles or antigens to confirm a reactive screening result
Nucleic Acid Test Detects HIV RNA and may be used when a very recent infection is suspected
Virological Testing for Infants Detects HIV genetic material because standard antibody tests are unreliable in young HIV-exposed infants
Viral-Load Test Measures the amount of HIV in the blood after diagnosis and monitors treatment response
CD4 Count Assesses immune function and helps evaluate advanced disease or opportunistic-infection risk

How is HIV Managed or Treated?

HIV is treated with antiretroviral therapy, commonly called ART. It uses a combination of medicines that block HIV at different stages of its replication cycle.

Treatment for HIV should begin as soon as possible after diagnosis. Its aims are to:

  • Reduce the viral load to an undetectable level

  • Protect and restore immune function

  • Prevent opportunistic infections

  • Prevent progression to AIDS

  • Reduce HIV-related illness and death

  • Prevent sexual transmission when viral suppression is maintained

ART must be taken consistently. Missed or irregular doses may allow the virus to multiply and can contribute to treatment failure or drug resistance. Patients also require follow-up for viral load, medicine safety, coinfections and other health needs.

Common Medicines Used to Treat HIV

HIV cannot currently be cured with medicines. Treatment aims to suppress viral replication, preserve CD4 cells, prevent complications and reduce the risk of transmission.

Common medications for HIV treatment include:

  • Tenofovir + Lamivudine + Dolutegravir: This fixed-dose combination, commonly called TLD, is a preferred first-line regimen for many adults and adolescents under India’s HIV programme.

  • Abacavir + Lamivudine + Dolutegravir: This combination may be used in selected patients, including certain children or people for whom tenofovir is unsuitable.

  • Zidovudine + Lamivudine: These medicines may form part of an alternative regimen when the preferred combination is unsuitable.

  • Efavirenz: Efavirenz may be included in selected alternative regimens when dolutegravir cannot be used.

  • Atazanavir/Ritonavir or Lopinavir/Ritonavir: These boosted protease inhibitors may be used in selected second-line regimens under specialist supervision.

  • Cotrimoxazole: Cotrimoxazole may prevent or treat certain opportunistic infections in people with advanced immune suppression. It does not suppress HIV and should not be presented as an antiretroviral medicine.

Note: HIV medicines must be prescribed and monitored by a qualified healthcare professional. HIV treatment is generally lifelong. Do not start, stop or change HIV medicines without medical advice.

Living with HIV: Daily Challenges and Patient Well-Being

HIV is a long-term health condition that usually requires lifelong treatment and monitoring. Effective ART allows many people to work, study, maintain relationships and lead healthy lives.

  1. Daily Challenges
    • Treatment Adherence: ART must be taken regularly, even when the person feels healthy.
    • Stigma and Disclosure: Fear of discrimination may affect relationships, employment, and access to healthcare.
    • Medical Appointments: Viral load monitoring and follow-up visits may need to be planned around work or family responsibilities.
    • Relationships and Sexual Health: Patients may need support regarding disclosure, safer sex, conception and U=U.
  2. Patient Safety and Well-Being
    • Medicine Safety: Doctors should be informed of all medicines and supplements to prevent interactions.
    • Mental Health: Persistent anxiety, depression, isolation or fear of disclosure may require counselling.
    • Confidentiality: HIV-related information should be handled respectfully and confidentially.
    • Support Services: ART centres and Care and Support Centres may provide adherence counselling, psychosocial support and referrals.
  3. Expenses
    • ART and Public Services: ART and several HIV-related diagnostic and support services are provided free of cost by India’s national programme.
    • Private Monitoring: Private viral-load, CD4 and specialist services may create recurring expenses.
    • Opportunistic Infections: Tuberculosis, severe infections or hospital admission may add substantial costs.

What is the Prognosis of HIV/AIDS?

The prognosis of HIV has improved substantially with effective antiretroviral therapy. When HIV is diagnosed early and ART is taken consistently, the viral load can become undetectable, immune function can recover and progression to AIDS can usually be prevented.

People who maintain viral suppression can lead long and healthy lives. An undetectable viral load also means that HIV will not be transmitted through sex. However, undetectable does not mean cured. ART must continue unless a qualified HIV specialist changes the treatment plan.

How Can I Prevent HIV Infection?

Some measures can minimise the risk of infection transmission and prevent HIV are:

  • Use condoms correctly during anal or vaginal sex.

  • Consider pre-exposure prophylaxis, or PrEP, when there is an ongoing risk of acquiring HIV.

  • Seek post-exposure prophylaxis, or PEP, within 72 hours of a possible exposure.

  • Never share needles, syringes or injecting equipment.

  • Use sterile equipment for injections, tattoos and piercings.

  • Get tested for HIV and other sexually transmitted infections when appropriate.

  • Start and continue ART after an HIV diagnosis.

  • Maintain an undetectable viral load to prevent sexual transmission.

  • Ensure donated blood and organs undergo the required screening.

  • Receive PPTCT care during pregnancy, delivery and breastfeeding.

  • Follow clinical advice on maternal ART, infant prophylaxis and infant feeding.

HIV Treatment Cost in India

The cost of HIV treatment in India varies considerably. Government ART services provide medicines free of cost, while private care may involve medicine, consultation and laboratory expenses.

The table below shows the approximate treatment costs of HIV:

Treatment Component Approximate Cost Range in India
ART at NACO ART Centre Free
Private HIV Medicine, 30 Tablets Around ₹3,000 - ₹3,600 per month
HIV Viral Load Test ₹5,000 - ₹6,500 per test
HIV Monitoring Panel ₹4,700 - ₹6,500 per panel
CD4 count ₹1,100 - ₹2,500
Treatment of Opportunistic Infections Additional cost depending on infection and treatment setting
Hospitalisation for HIV-Related Complications ₹5,000 to ₹10,000 per day

Note: The above figures are indicative prices and may vary in reality. Patients should verify the current price directly with the healthcare provider or laboratory before estimating treatment expenses.

Does Health Insurance Cover HIV?

Yes. Health insurance provides coverage for HIV treatment costs in India. It covers the cost of medically necessary in-patient hospitalisation, day care procedures, ambulance charges, second medical opinion, and pre & post-hospitalisation expenses. Some health insurance for HIV patients may also offer an HIV/AIDS hospital cash benefit.

Routine ART, regular outpatient consultations and monitoring tests may be covered only if the policy comes with an OPD benefit. Make sure to read the policy terms and conditions carefully to know the exact scope of coverage.

However, HIV is covered after a waiting period ranging from 30 days to 90 days under most plans.

How Much Health Insurance Coverage is Needed for HIV Treatment?

Antiretroviral therapy is available free of cost through government ART centres. Therefore, health insurance may be more useful for hospitalisation, treatment of opportunistic infections, intensive care and other medical conditions rather than routine ART expenses.

A health insurance policy with a sum insured of at least ₹10 lakh should be purchased to get adequate protection against the cost of hospitalisation for HIV. People seeking greater protection may opt for a higher coverage amount or buy a top-up insurance plan to enhance their coverage.

Frequently Asked Questions (FAQs)

  • Q1. What is HIV?

    Ans. HIV is a virus that attacks CD4 cells and continues to weaken the immune system if it is left untreated.
  • Q2. What is the difference between HIV and AIDS?

    Ans. HIV is the virus. AIDS is the most advanced stage of untreated or uncontrolled HIV infection.
  • Q3. How does HIV spread?

    Ans. HIV spreads through certain bodily fluids, mainly during sex, shared-needle exposure or transmission during pregnancy, birth or breastfeeding.
  • Q4. Does HIV spread through normal contact?

    Ans. No. HIV does not spread through hugging, shaking hands, sharing food, toilets or ordinary household contact.
  • Q5. What are the early symptoms of HIV?

    Ans. Early HIV may cause fever, rash, sore throat, swollen lymph nodes, muscle pain or fatigue. Some people may have no symptoms.
  • Q6. Can a person have HIV without symptoms?

    Ans. Yes. HIV may cause no noticeable symptoms for several years. Testing is the only reliable way to know.
  • Q7. How is HIV diagnosed?

    Ans. HIV is diagnosed through screening and confirmatory blood tests performed according to an approved testing algorithm.
  • Q8. Is there a cure for HIV?

    Ans. There is currently no cure for HIV. However, antiretroviral therapy (ART) can suppress the virus and help people with HIV live long and healthy lives.
  • Q9. What is ART?

    Ans. ART refers to a combination of antiretroviral medicines often prescribed by doctors to prevent the progression of HIV in affected individuals.
  • Q10. What does U=U mean?

    Ans. U=U means that a person who maintains an undetectable viral load does not transmit HIV through sex.
  • Q11. Does HIV always progress to AIDS?

    Ans. No. Consistent ART can prevent HIV from progressing to AIDS.
  • Q12. What is PEP?

    Ans. PEP is emergency HIV-prevention medicine that should be started within 72 hours after a possible exposure.
  • Q13. What is PrEP?

    Ans. PrEP is a medicine taken by an HIV-negative person to reduce the risk of acquiring HIV.
  • Q14. Can a woman living with HIV have an HIV-negative baby?

    Ans. Yes. ART, pregnancy care, infant preventive treatment and follow-up can greatly reduce the chances of HIV transmission to the baby.
  • Q15. Is HIV treatment free in India?

    Ans. Yes. Lifelong ART and several related services are available free through government ART centres under NACO.
  • References

    • https://www.cdc.gov/hiv/about/index.html

    • https://www.cdc.gov/hiv/testing/index.html

    • https://pubmed.ncbi.nlm.nih.gov/16570678/

    • https://naco.mohfw.gov.in/division/care-support-and-treatment/

Other Health Disease Pages